▼ SELL
10b5-1 Plan
$ Value
$63K
Shares
2,061
Price
$31
Filed
Mar 16
Insider
Name
Hopman Mark
Title
Chief Commercial Officer
CIK
0002048497
Roles
Officer
Transaction Details
Transaction Date
2025-12-04
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
136,216
Footnotes
The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. | Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025. | The weighted average sale price for the transaction reported was $30.6610 and the range of prices were between $30.02 and $31.0024. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Filing Info
Hopman Mark's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-04 | BBNX | ▼ | $4K |
| 2026-03-02 | BBNX | ▼ | $10K |
| 2026-02-27 | BBNX | A | $0 |
| 2026-02-27 | BBNX | A | $0 |
| 2026-02-27 | BBNX | A | $0 |
| 2025-12-04 | BBNX | ▼ | $63K |
| 2025-12-02 | BBNX | ▼ | $25K |
| 2025-09-05 | BBNX | M | $58K |
| 2025-09-05 | BBNX | ▼ | $235K |
| 2025-09-05 | BBNX | M | $0 |
Other Insiders at BBNX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hopman Mark
Chief Commercial Officer
|
— | $40K | 2026-03-04 |
|
Mensinger Mike
Chief Product Officer
|
— | $13K | 2026-03-02 |
|
Feider Stephen
Chief Financial Officer
|
— | $18K | 2026-03-02 |
|
Saint Sean
President & CEO
|
— | $42K | 2026-03-02 |
|
Russell Steven Jon
Chief Medical Officer
|
— | $43K | 2026-03-02 |